ALEXA MORRISSEY: Open Payments
NPI 1487012373 · NASHUA, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 8 payments from 5 companies in 2025. Trend: 2023 $275 · 2024 $234 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| ABBVIE INC. | 1 | $29 |
| Novo Nordisk Inc | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $23 |
Products named: ENTYVIO, XIFAXAN, CREON, Wegovy.
Industry payments across NH — which companies pay providers there.
